Suramin

Suramin
Trade Name Metaret
Orphan Indication Hormone-refractory prostate cancer
USA Market Approval USA
USA Designation Date 1997-05-06 00:00:00
Sponsor Warner-Lambert Company;Parke-Davis Pharmaceutical Research Division, 2800 Plymouth Road;Ann Arbor, Michigan, 48105